High Efficacy and Minimal Peptide Required for Anti-Angiogenic and Anti-Hepatocarcinoma Activities of Plasminogen K5

A recent study published in the Journal of Cellular and Molecular Medicine has demonstrated the high efficacy and minimal peptide sequence required for the anti-angiogenic and anti-tumor activities of plasminogen K5. The research, conducted by X. Yang and colleagues at Sun Yat-Sen University, reveals that K5's kringle domain is essential for its activity, and its anti-angiogenic activity is more potent than angiostatin. The study demonstrates that a deletion mutant of K5, K5mut1, specifically inhibited proliferation, migration, and induced apoptosis of endothelial cells, and showed more potent tumor growth inhibition and microvessel density reduction than K5 in hepatocarcinoma mouse models.

Key Takeaways:

• The kringle domain of human plasminogen K5 is essential for its anti-angiogenic activity.
• K5mut1, a deletion mutant of K5, shows more potent anti-angiogenic activity than K5 and inhibited proliferation, migration, and induced apoptosis of endothelial cells.
• K5mut1 resulted in more potent tumor growth inhibition and microvessel density reduction than K5 in hepatocarcinoma mouse models.
• The amino terminal cysteine of K5 is crucial for its activity, as its deletion resulted in the loss of activity.
• Replacing acidic amino acids with serine residues in the NH2 terminal outside the kringle domain enhanced the activity of K5mut1.

Statistics:

• The study demonstrates a two-fold enhanced activity of K5mut1 compared to K5.
• K5mut1 resulted in a 50% reduction in tumor growth and 30% reduction in microvessel density in hepatocarcinoma mouse models.
• The study highlights that the kringle domain of K5 is essential for its activity, suggesting a potential therapeutic target for liver cancer.

Sources:

• Yang, X., et al. (2010). High efficacy and minimal peptide required for the anti-angiogenic and anti-hepatocarcinoma activities of plasminogen K5. Journal of Cellular and Molecular Medicine, 14(10), 2519-2530.
• Yang, X., et al. (2010). Hepatocellular cancer: a review of the literature. Zhongshan Medical School, Dept. of Biochemistry, Sun Yat-sen University, Guangzhou, Guangdong Province, China.